Industry: Healthcare
Published Date: December-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 319
Report ID: PMRREP32516
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Key Success Factors
4.1. Service Adoption Analysis
4.2. Key Regulations
4.3. Key promotional Strategies, By Key Players
4.4. PESTEL Analysis
4.5. Service Pricing Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global CMO/CDMO Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increase in R&D Spending
5.2.2. Growing Lifestyle Disease Prevalence
5.2.3. Cost of Services
5.2.4. Service Adoption Rate
5.2.5. Advancements in Technology
5.2.6. Changes in Regulatory Policies
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Services
6.1.2. By Product
6.1.3. By Expression Systems
6.1.4. By Company Size
6.1.5. By Scale of Operations
6.1.6. By Country
6.2. 2022 Market Scenario
7. Global CMO/CDMO Biotechnology Market Demand (in Value or Size in US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Services
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Services, 2016-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Services, 2023-2033
8.3.1. Stand-Alone Services
8.3.1.1. Cell Line Development
8.3.1.2. Development and Bio Manufacturing
8.3.1.3. Analytical Services
8.3.1.4. Fill finish
8.3.1.5. Packaging
8.3.1.6. Clinical Supply Services
8.3.2. Integrated
8.4. Market Attractiveness Analysis By Services
9. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By Product, 2016-2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2023-2033
9.3.1. Monoclonal Antibodies
9.3.2. Antibody Fragments
9.3.3. Recombinant Therapeutic Proteins
9.3.4. Viral Vector
9.3.5. Cell and Gene Therapy
9.3.6. Vaccine
9.4. Market Attractiveness Analysis By Product
10. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Expression Systems
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, By Expression Systems, 2016-2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Expression Systems, 2023-2033
10.3.1. Mammalian
10.3.2. Microbial
10.3.2.1. Bacteria
10.3.2.2. Yeast
10.4. Market Attractiveness Analysis By Expression Systems
11. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Company Size
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By Company Size, 2016-2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Company Size, 2023-2033
11.3.1. Small
11.3.2. Mid-sized
11.3.3. Large
11.3.4. Very large
11.4. Market Attractiveness Analysis By Company Size
12. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Scale of Operation
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis, By Scale of Operation, 2016-2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Scale of Operation, 2023-2033
12.3.1. Preclinical
12.3.2. Clinical
12.3.3. Commercial
12.4. Market Attractiveness Analysis By Scale of Operation
13. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2022
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Services
14.3.3. By Product
14.3.4. By Expression Systems
14.3.5. By Company Size
14.3.6. By Scale of Operation
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Services
14.4.3. By Product
14.4.4. By Expression Systems
14.4.5. By Company Size
14.4.6. By Scale of Operation
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
14.8.1. U.S. CMO/CDMO Biotechnology Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Services
14.8.1.2.2. By Product
14.8.1.2.3. By Expression Systems
14.8.1.2.4. By Company Size
14.8.1.2.5. By Scale of Operation
14.8.2. Canada CMO/CDMO Biotechnology Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Services
14.8.2.2.2. By Product
14.8.2.2.3. By Expression Systems
14.8.2.2.4. By Company Size
14.8.2.2.5. By Scale of Operation
15. Latin America CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Services
15.3.3. By Product
15.3.4. By Expression Systems
15.3.5. By Company Size
15.3.6. By Scale of Operation
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Services
15.4.3. By Product
15.4.4. By Expression Systems
15.4.5. By Company Size
15.4.6. By Scale of Operation
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
15.8.1. Mexico CMO/CDMO Biotechnology Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Services
15.8.1.2.2. By Product
15.8.1.2.3. By Expression Systems
15.8.1.2.4. By Company Size
15.8.1.2.5. By Scale of Operation
15.8.2. Brazil CMO/CDMO Biotechnology Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Services
15.8.2.2.2. By Product
15.8.2.2.3. By Expression Systems
15.8.2.2.4. By Company Size
15.8.2.2.5. By Scale of Operation
15.8.3. Argentina CMO/CDMO Biotechnology Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Services
15.8.3.2.2. By Product
15.8.3.2.3. By Expression Systems
15.8.3.2.4. By Company Size
15.8.3.2.5. By Scale of Operation
16. Europe CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Services
16.3.3. By Product
16.3.4. By Expression Systems
16.3.5. By Company Size
16.3.6. By Scale of Operation
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Services
16.4.3. By Product
16.4.4. By Expression Systems
16.4.5. By Company Size
16.4.6. By Scale of Operation
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
16.8.1. Germany CMO/CDMO Biotechnology Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Services
16.8.1.2.2. By Product
16.8.1.2.3. By Expression Systems
16.8.1.2.4. By Company Size
16.8.1.2.5. By Scale of Operation
16.8.2. Italy CMO/CDMO Biotechnology Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Services
16.8.2.2.2. By Product
16.8.2.2.3. By Expression Systems
16.8.2.2.4. By Company Size
16.8.2.2.5. By Scale of Operation
16.8.3. France CMO/CDMO Biotechnology Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Services
16.8.3.2.2. By Product
16.8.3.2.3. By Expression Systems
16.8.3.2.4. By Company Size
16.8.3.2.5. By Scale of Operation
16.8.4. U.K. CMO/CDMO Biotechnology Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Services
16.8.4.2.2. By Product
16.8.4.2.3. By Expression Systems
16.8.4.2.4. By Company Size
16.8.4.2.5. By Scale of Operation
16.8.5. Spain CMO/CDMO Biotechnology Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Services
16.8.5.2.2. By Product
16.8.5.2.3. By Expression Systems
16.8.5.2.4. By Company Size
16.8.5.2.5. By Scale of Operation
16.8.6. BENELUX CMO/CDMO Biotechnology Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Services
16.8.6.2.2. By Product
16.8.6.2.3. By Expression Systems
16.8.6.2.4. By Company Size
16.8.6.2.5. By Scale of Operation
16.8.7. Russia CMO/CDMO Biotechnology Market Analysis
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Services
16.8.7.2.2. By Product
16.8.7.2.3. By Expression Systems
16.8.7.2.4. By Company Size
16.8.7.2.5. By Scale of Operation
17. East Asia CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Services
17.3.3. By Product
17.3.4. By Expression Systems
17.3.5. By Company Size
17.3.6. By Scale of Operation
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Services
17.4.3. By Product
17.4.4. By Expression Systems
17.4.5. By Company Size
